Back to Journals » OncoTargets and Therapy » Volume 14

Dramatic Responses of Recurrent Upper Urinary Tract Urothelial Carcinoma Harboring FGFR3 and TP53 Activating Mutations to Pembrolizumab in Combination with Erdafitinib: A Case Report

Total article views   HTML views PDF downloads Totals
4,764 Dovepress* 4,009+ 698 4,707
PubMed Central* 755 162 917
Totals 4,764 860 5,624
*Since 25 March 2021

View citations on PubMed Central and Google Scholar